282 related articles for article (PubMed ID: 19151252)
1. Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure.
Okada H; Takemura G; Kosai K; Tsujimoto A; Esaki M; Takahashi T; Nagano S; Kanamori H; Miyata S; Li Y; Ohno T; Maruyama R; Ogino A; Li L; Nakagawa M; Nagashima K; Fujiwara T; Fujiwara H; Minatoguchi S
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H616-26. PubMed ID: 19151252
[TBL] [Abstract][Full Text] [Related]
2. Cellular preservation therapy in acute myocardial infarction.
Abbate A; Biondi-Zoccai GG; Van Tassell BW; Baldi A
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H563-5. PubMed ID: 19202003
[No Abstract] [Full Text] [Related]
3. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure.
Li Y; Takemura G; Kosai K; Takahashi T; Okada H; Miyata S; Yuge K; Nagano S; Esaki M; Khai NC; Goto K; Mikami A; Maruyama R; Minatoguchi S; Fujiwara T; Fujiwara H
Circ Res; 2004 Sep; 95(6):627-36. PubMed ID: 15297380
[TBL] [Abstract][Full Text] [Related]
4. Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction.
Li L; Okada H; Takemura G; Kosai K; Kanamori H; Esaki M; Takahashi T; Goto K; Tsujimoto A; Maruyama R; Kawamura I; Kawaguchi T; Takeyama T; Fujiwara T; Fujiwara H; Minatoguchi S
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1504-13. PubMed ID: 19684189
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Fas-associated apoptosis in granulation tissue cells accompanies attenuation of postinfarction left ventricular remodeling by olmesartan.
Kanamori H; Takemura G; Li Y; Okada H; Maruyama R; Aoyama T; Miyata S; Esaki M; Ogino A; Nakagawa M; Ushikoshi H; Kawasaki M; Minatoguchi S; Fujiwara H
Am J Physiol Heart Circ Physiol; 2007 May; 292(5):H2184-94. PubMed ID: 17208988
[TBL] [Abstract][Full Text] [Related]
6. Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling.
Ogino A; Takemura G; Kanamori H; Okada H; Maruyama R; Miyata S; Esaki M; Nakagawa M; Aoyama T; Ushikoshi H; Kawasaki M; Minatoguchi S; Fujiwara T; Fujiwara H
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2271-80. PubMed ID: 17644576
[TBL] [Abstract][Full Text] [Related]
7. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
Minatoguchi S; Takemura G; Chen XH; Wang N; Uno Y; Koda M; Arai M; Misao Y; Lu C; Suzuki K; Goto K; Komada A; Takahashi T; Kosai K; Fujiwara T; Fujiwara H
Circulation; 2004 Jun; 109(21):2572-80. PubMed ID: 15123535
[TBL] [Abstract][Full Text] [Related]
8. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure.
Okada H; Takemura G; Kosai K; Li Y; Takahashi T; Esaki M; Yuge K; Miyata S; Maruyama R; Mikami A; Minatoguchi S; Fujiwara T; Fujiwara H
Circulation; 2005 May; 111(19):2430-7. PubMed ID: 15867170
[TBL] [Abstract][Full Text] [Related]
9. Effect of a long-term treatment with a low-dose granulocyte colony-stimulating factor on post-infarction process in the heart.
Okada H; Takemura G; Li Y; Ohno T; Li L; Maruyama R; Esaki M; Miyata S; Kanamori H; Ogino A; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
J Cell Mol Med; 2008 Aug; 12(4):1272-83. PubMed ID: 18298650
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure.
Ahmad F; Lal H; Zhou J; Vagnozzi RJ; Yu JE; Shang X; Woodgett JR; Gao E; Force T
J Am Coll Cardiol; 2014 Aug; 64(7):696-706. PubMed ID: 25125302
[TBL] [Abstract][Full Text] [Related]
11. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
[TBL] [Abstract][Full Text] [Related]
12. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
13. ANG II type 1A receptor signaling causes unfavorable scar dynamics in the postinfarct heart.
Li Y; Takemura G; Okada H; Miyata S; Kanamori H; Maruyama R; Esaki M; Li L; Ogino A; Ohno T; Kondo T; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H946-53. PubMed ID: 17028164
[TBL] [Abstract][Full Text] [Related]
14. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
15. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
Sumida A; Horiba M; Ishiguro H; Takenaka H; Ueda N; Ooboshi H; Opthof T; Kadomatsu K; Kodama I
Cardiovasc Res; 2010 Apr; 86(1):113-21. PubMed ID: 19969622
[TBL] [Abstract][Full Text] [Related]
16. Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction.
Takano H; Qin Y; Hasegawa H; Ueda K; Niitsuma Y; Ohtsuka M; Komuro I
J Mol Med (Berl); 2006 Mar; 84(3):185-93. PubMed ID: 16418824
[TBL] [Abstract][Full Text] [Related]
17. Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism.
Sun D; Yang F
Biochem Biophys Res Commun; 2017 Apr; 486(2):329-335. PubMed ID: 28302481
[TBL] [Abstract][Full Text] [Related]
18. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction.
Kubota A; Takano H; Wang H; Hasegawa H; Tadokoro H; Hirose M; Kobara Y; Yamada-Inagawa T; Komuro I; Kobayashi Y
J Mol Cell Cardiol; 2016 Feb; 91():72-80. PubMed ID: 26739213
[TBL] [Abstract][Full Text] [Related]
19. The antiapoptotic effect of granulocyte colony-stimulating factor reduces infarct size and prevents heart failure development in rats.
Baldo MP; Davel AP; Damas-Souza DM; Nicoletti-Carvalho JE; Bordin S; Carvalho HF; Rodrigues SL; Rossoni LV; Mill JG
Cell Physiol Biochem; 2011; 28(1):33-40. PubMed ID: 21865846
[TBL] [Abstract][Full Text] [Related]
20. Selective homocysteine lowering gene transfer improves infarct healing, attenuates remodelling, and enhances diastolic function after myocardial infarction in mice.
Muthuramu I; Jacobs F; Singh N; Gordts SC; De Geest B
PLoS One; 2013; 8(5):e63710. PubMed ID: 23675503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
